AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 151 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $43,000 | -52.2% | 11,008 | +0.3% | 0.00% | – |
| Q1 2019 | $90,000 | +47.5% | 10,974 | -0.6% | 0.00% | – |
| Q4 2018 | $61,000 | -98.6% | 11,036 | -97.5% | 0.00% | -100.0% |
| Q1 2016 | $4,296,000 | -0.0% | 445,000 | -0.0% | 0.02% | +4.5% |
| Q4 2015 | $4,297,000 | 0.0% | 445,100 | 0.0% | 0.02% | -8.3% |
| Q3 2015 | $4,297,000 | -79.1% | 445,100 | -50.0% | 0.02% | -55.6% |
| Q2 2015 | $20,580,000 | +85.2% | 889,408 | +100.0% | 0.05% | -11.5% |
| Q1 2015 | $11,110,000 | -4.6% | 444,704 | -0.0% | 0.06% | -6.2% |
| Q4 2014 | $11,641,000 | -5.8% | 444,804 | -0.0% | 0.06% | -40.4% |
| Q3 2014 | $12,362,000 | -0.0% | 444,904 | 0.0% | 0.11% | -1.8% |
| Q2 2014 | $12,364,000 | – | 444,904 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |